BSECompany Update29 Aug 2026 · 29 Aug 2026, 02:55 pm
Analyst/Investor Meet Outcome
3B BlackBio Dx Ltd · 532067
✦ AI SummaryResults
3B BlackBio Dx Ltd held an analyst/investor meet on August 29, 2026, where they interacted with Param Capital. The company reiterated information shared through an investor presentation for Q1-FY27, which was available in the public domain. No unpublished price-sensitive information was disclosed.
Analysis Scores
Earnings Impact5/10
Growth Catalyst2/10
Governance Concern1/10
Regulatory Risk1/10
Balance Sheet Risk1/10
Liquidity Impact8/10
Market Sentiment6/10
✦ Ask a Question
Ask anything about this announcement — AI will answer based on the filing content.
Full Announcement
3B BlackBio Dx Ltd - 532067 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
Attachments (1)
📄pdf
Download →
4f8a615e-bba3-48b1-98eb-377f4027efb5.pdf
View document text
(Formerly – Kilpest India Limited)
Ref. No.P-66/2026-27/30
August 29, 2026
The Relationship Manager,
Department of Corporate Relations
BSE Limited,
P.J. Towers, Dalal Street
Fort, MUMBAI – 400 001
Dear Sir,
Sub: Outcome of Schedule of Analyst/ Investor Meeting
Ref: Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
In continuation to our earlier letter Ref. No.P-66/2026-27/29 dated 25th August, 2026 respectively we wish to
inform you that, 3B BlackBio Dx Limited (the ‘Company’) interacted one to one with Param Capital, Mumbai
On Saturday, 29th August, 2026 at 13:00 hrs India Time. The meeting concluded at 14:00 hrs India Time.
Please note that information which is already available in public domain was discussed and no unpublished
price sensitive information pertaining to the company was shared with the investor.
During this investor meeting , the company reiterated the information shared by it through Investor
Presentation of Q1-FY27, which was earlier intimated to the Stock Exchanges vide Ref. No.P66/2026-27/27
dated 13th August, 2026.
Please find below the web link of the presentation placed before investors after the declaration of the financial
results for the quarter ended 30-06-2026 and the above mentioned investor.
https://www.kilpest.com/upload/Investor's%20Presentation%20August%202026.pdf
This is for your information, action and record please.
Thanking You,
For 3B BlackBio Dx Limited (Formerly, Kilpest India Limited)
Nikhil Kuber Dubey
Whole Time Director
DIN: 00538049
Encl: As above
Regd. Office & Factory : 7-C | Industrial Area | Govindpura | Bhopal – 462023 | (M.P.) | INDIA CIN : L24211MP1972PLC001131
Ph.: 91-755-2586536, 2586537 Email : info@kilpest.com Visit us at : www.kilpest.com